Skip to content

To see the effect of kanchnar guggulu and cystogrit diamond in stanagranthi (fibroadenoma breast)

Comparative evaluation of kanchnar guggulu and cystogrit diamond in stanagranthi (fibroadenoma breast) - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057893
Enrollment
60
Registered
2023-09-20
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D249- Benign neoplasm of unspecified breast

Interventions

None listed

Sponsors

Patanjali Ayurvedic College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Female patients having classical signs and symptoms of Stana Granthi is included viz. mobile lump in the breast and / or pain in the site of lump. 2. Patient fulfilling the diagnostic criteria of Stana Granthi i.e. investigation revealing presence of fibroadenoma breast. 3. Female patients will be selected between the age group of 15 – 45 years, irrespective of religion, occupation and economic status. 4. Female patients who are willing for trial.

Exclusion criteria

Exclusion criteria: 1. Females of age below 15 years and above 45 years will be exclued. 2. Patients having history of severe systemic illness like Peptic ulcer, Inflammatory Bowel Diseases, DM, HIV 1 & 2, HTN, Pregnancy, Crohn’s Disease, Ulcerative Colitis, Malignancy & Tuberculosis will be excluded. 3. Participation in any other clinical trial during past 06 months. 4. Female patients not willing for trial.

Design outcomes

Primary

MeasureTime frame
Subjective criteria Improvement in pain and consistency of fibroadenoma of breast Objective criteria Reduction in size and number of fibroadenoma of breastTimepoint: 0 day 30th day 60th day 90th day

Secondary

MeasureTime frame
After follow up- 1. Any recurrences. 2. Any Adverse Drug Reactions (ADR) will be noted and intimidated to ADR Department.Timepoint: 1 month

Countries

India

Contacts

Public ContactDr Mansi

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar

surgeonsaurabh@gmail.com9021709911

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026